Detail of the clinical trial

Title of the trial A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of AG-120 in Combination with Azacitidine in Subjects ? 18 Years of Age with Previously Untreated Acute Myeloid Leukemia with an IDH1 Mutation
EudraCT number 2016-004907-30
Protocol number AG120-C-009
Sponsor Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139-4169, United States of America
Indications Hemato-oncology
Diagnosis Acute Myeloid Leukemia with an IDH1 Mutation
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2017
Date of approval by Institute (SÚKL) 10.10.2017
Date of approval by EC 4.10.2017
Date of initiation CT in ČR 14.9.2018
Date of ending CT in ČR
Notice
Sites Fakultní nemocnice Královské Vinohrady,Interní hematologická klinika,Šrobárova 50,Praha 10,100 34 (discontinued)
Fakultní nemocnice Brno,Interní hematologická a onkologická klinika,Jihlavská 20,Brno,625 00
Všeobecná fakultní nemocnice v Praze,I. interní klinika - klinika hematologie ,U Nemocnice 2,Praha 2,128 08
Fakultní nemocnice Ostrava,Klinika hematoonkologie,17. listopadu 1790,Ostrava - Poruba,708 52

‹‹ Back to list